Cagrilintide 5mg - Third-Party Test Results
Manufacturer: LeoLab™
Sample: Cagrilintide 5mg
Date: 25 MAR 2025
LeoLab’s Cagrilintide 5mg (Batch G60147) has recently undergone independent third-party testing by Janoshik Analytical, a trusted name in peptide quality control. The results reaffirm LeoLab’s commitment to high standards in peptide production and transparency.
Test Summary
-
Analyzed Sample: Cagrilintide 5mg
-
Batch Number: G60147
-
Purity: 99.516%
-
Measured Mass: 4.68 mg
-
Date of Analysis: 25 March 2025
-
Task ID: 60438
Review & Interpretation
The standout metric from the analysis is the exceptional purity of 99.516%, which comfortably exceeds industry benchmarks for pharmaceutical-grade peptides. This level of purity minimizes the risk of contaminants or byproducts, enhancing both safety and effectiveness in research and clinical applications.
The actual mass of 4.68 mg is consistent with the labeled dosage, indicating precise manufacturing and filling processes. This supports reliability in dosing, which is critical for consistent experimental or therapeutic outcomes.
Purity 99.516%
Mass 4.68 mg
